Diagnostics/Pathology - Listed on 06 December 2024
Suraksha Diagnostic (Diagnostics/Pathology) closed its IPO window in 2024 and listed on NSE and BSE on 06 December 2024 at an upper band issue price of Rs 441, opening at Rs 438 for a listing gain of -0.7% and closing day one at Rs 417.25 (-5.4% on closing basis). The IPO was subscribed 1.27x overall - QIB 1.74x, HNI/NII 1.40x, Retail 0.94x. The total issue size was Rs 846.25 Cr (Fresh Issue Rs 0 Cr, OFS Rs 846.25 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Diagnostics/Pathology
Suraksha Diagnostic operates in the Diagnostics/Pathology space. The company’s listed profile is shaped by its operating niche, customer demand and ability to convert that demand into steady cash flows. Investors should read its exchange filings alongside the headline listing numbers for a fuller view of the business.
Issue structure, listing outcome and context
The Suraksha Diagnostic issue was offered at an upper price of Rs 441 and raised approximately Rs 846.25 crore. The final outcome reflected a mix of subscription demand, valuation, market conditions and the company’s own operating story. Fresh issue and offer-for-sale details, where available, are shown in the issue metrics below.
Number of times each investor category subscribed by close of Day 3.
How overall subscription built up across the three-day issue window.
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | Rs 0 | +1.59% |
| Day 2 | Rs 0 | +1.13% |
| Day 3 | Rs 0 | +1.13% |
| Day 4 | Rs 0 | +0.91% |
| Day 5 | Rs 7 | +0.68% |
Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.
How the broader market moved around the Suraksha Diagnostic IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Suraksha Diagnostic IPO listed at -0.7% versus the upper issue price of Rs 441 on 06 December 2024.
Suraksha Diagnostic IPO was subscribed 1.27x overall. QIB portion was subscribed 1.74x, HNI / NII 1.40x and Retail 0.94x.
IPO GMP started at Rs 0 on Day 1 and moved to Rs 7 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.